Type 1 Diabetes



The SUNRISE study is a prospective, multi-center, double-blind, randomized, placebo-controlled trial in subjects aged 18.0 to <41.0 years diagnosed with T1D within 5 years.



The purpose of the 321 trial is to evaluate the safety of the Advanced Hybrid Closed Loop system (AHCL) in pediatric type 1 diabetes subjects age 7 – 13 in a home setting. The main objective in conducting this research is to collect data from patients who use the AHCL system at home, at work, […]

Can’t find a study that works for you?

Subscribe for Information on Other Studies

Fill out the form below an we will let you know when a study becomes available that you may be interested in:

Interested in other Studies
What other studies are you interested in?